Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Rhea-AI Summary

Resmed (NYSE: RMD, ASX: RMD) has announced it will release its third quarter fiscal 2025 financial and operational results on Wednesday, April 23, 2025, after the NYSE market close. The company will host a webcast to discuss the results at 1:30 p.m. PDT / 4:30 p.m. EDT on the same day.

The earnings webcast will be accessible through the investor relations section of Resmed's website. A replay will be available approximately two hours after the webcast, with a phone replay option available until May 7, 2025. Resmed, operating in 140 countries, specializes in AI-powered digital health solutions, cloud-connected devices, and intelligent software for home healthcare, focusing on sleep and breathing care.

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Earnings webcast details:

	•	Location:	https://investor.resmed.com
	•	Date:	Wednesday, April 23, 2025
	•	Time:	1:30 p.m. PDT / 4:30 p.m. EDT
	•	International:	London, Wednesday, April 23, 2025, 9:30 p.m. BST
			Sydney, Thursday, April 24, 2025, 6:30 a.m. AEST

Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.

A replay of the earnings webcast will be accessible on Resmed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from April 23, 2025, until May 7, 2025, at:

	•	U.S.: +1 877.660.6853
	•	International: +1 201.612.7415
	•	Conference ID: 13752711

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

For investors	For media
+1 858.836.5000	+1 619.510.1281
investorrelations@Resmed.com	news@Resmed.com

FAQ

When will Resmed (RMD) release its Q3 2025 earnings report?

Resmed will release its Q3 fiscal 2025 earnings on Wednesday, April 23, 2025, after the NYSE market close.

How can investors access Resmed's (RMD) Q3 2025 earnings call?

Investors can access the earnings call exclusively via webcast at investor.resmed.com at 1:30 p.m. PDT / 4:30 p.m. EDT on April 23, 2025.

How long will Resmed's (RMD) Q3 2025 earnings call replay be available?

The phone replay will be available from April 23 to May 7, 2025, while the webcast replay will be available on Resmed's website approximately two hours after the call.

What is Resmed's (RMD) current international market presence?

Resmed operates in 140 countries, providing AI-powered digital health solutions and cloud-connected devices for sleep and breathing care.